Find your next paid study

Massachusetts General HospitalNCT06265272

~$10 – $750

Phase 2

IIT2022-05-Sankar-BELIEVE: Phase II Study of Bevacizumab in Combination With Chemoimmunotherapy and Maintenance Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases

This clinical trial aims to assess whether the addition of bevacizumab to atezolizumab and chemotherapy can improve response to treatment and progression-free …

Extensive-stage Small-cell Lung CancerLiver Metastases

Carcinoma, HepatocellularLiver Cell Carcinoma

~$10 – $7,500

Kamya SankarNCT05588388

Phase 2

Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma

The investigators hypothesize that the addition of Tislelizumab after definitive local therapy for locally advanced inoperable Hepatocellular carcinoma (HCC) w…

Rutgers, The State University of New JerseyNCT05366829

Alcohol Use DisorderAlcohol-associated Liver Disease

Feasibility and Acceptability of a Novel Implementation Intervention to Promote Alcohol Use Disorder Treatment in Hepatology Clinics

The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use …

Yale UniversityNCT07525258

Post-Operative Cosmesis and Skin Closure Methods After Cesarean Section

Given the high numbers of cesarean deliveries being performed today, there has been interest in optimizing surgical techniques. Several recent reviews have sum…

Cesarean Delivery

Wake Forest University Health SciencesNCT06412978

Breast CancerLiver CancerProstate Cancer

Diversity and Inclusion in Research Underpinning Trials

This proposal brings together multidisciplinary teams from four New York City institutions charged with reducing cancer disparities that affect approximately t…

Icahn School of Medicine at Mount SinaiNCT05146297

Phase 1

A Three-Part, Phase 1/2a, Randomized, Double-blind, Placebo-Controlled, Single and Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of ALN-PNP, an siRNA Targeting PNPLA3, in Healthy Adults and Adult Participants With MASLD

This study is researching an experimental drug called ALN-PNP (called "study drug"). This is a first in human study. The study drug is not approved by any publ…

Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Regeneron PharmaceuticalsNCT05648214

~$10 – $8,750

vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC

This trial will provide the maximum tolerated dose for radiation therapy for liver tumors and describe the toxicity profile using the vGRID therapy technique. …

Liver Cancer

University of Kansas Medical CenterNCT05727787

Phase 2

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety o…

Non-Alcoholic Fatty Liver DiseaseNAFLDPediatric NAFLD

PregnancyLabor and DeliveryLabor Analgesia

~$10 – $7,500

Justin RyderNCT03867487

Phase 3

Determination of the 90% Effective Volume (ED90) of Epidural 0.1% Ropivacaine and Fentanyl for Labor Analgesia Initiation in Patients Receiving a Dural-Puncture Epidural Technique

This study is being done to determine the most effective dose of medicine to use to initially provide effective pain relief within the first 30 minutes of rece…

University of California, San FranciscoNCT07076368

~$10 – $5,625

Phase 4

The Effect of Antibiotics on Latency in Previable Prelabor Rupture of Membranes Between 18 0/7 and 22 6/7 Weeks Gestational Age

This study is a non-blinded, prospective, randomized controlled trial designed to compare the effect of outpatient oral antibiotics (i.e., amoxicillin and azit…

Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture)Rupture of Membranes; PrematureRupture of Membranes; Premature, Affecting Fetus+3 more

Liver Cancer Disparities in American Indian and Alaska Native Persons

We are performing a pilot and feasibility randomized controlled trial (RCT) of HCC screening by US + AFP every 6 months (n=100), the current standard-of-care, …

Hepatocellular CarcinomaCirrhosis, LiverHepatitis B